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Abstract. After a sinus lifting procedure, the compartment around the implants under
the sinus mucosal lining in the sinus floor is filled with a blood clot from
surrounding bleeding. The aim of this study was to evaluate the feasibility of bone
formation following graftless sinus lifting with the simultaneous placement of
dental implants. Thirty graftless sinus lifting procedures were performed and 72
dental implants placed in 18 consecutive patients, using the lateral window
approach. Clinical and radiological follow-up was conducted throughout the 6-
month healing period. Biopsies of 30 cases were collected at 6 months post-
treatment: 15 biopsies were taken from the newly formed bone near the basal floor
and 15 from the newly formed bone near the elevated membrane. New bone
consolidation in the maxillary sinus was apparent radiologically and histologically
at 6 months after sinus augmentation, providing an average 6.14  1.34 mm of
bone-gain. Based on histological analysis and histomorphometric data, the
consolidated bone in the augmented sinus comprised 56.7  11.9% to
59.9  13.4% vital bone tissue. Out of the 72 implants placed, only four failed,
indicating a 94% overall implant survival rate. Based on this case series, blood clot
can be considered autologous osteogenic graft material, to which osteoprogenitors
can migrate, differentiate, and regenerate bone.0901-5027/0901147 + 07 # 2016 The Author(s). Published by Elsevier Ltd on behalf of International Ass
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Available online 31 May 2016Sinus lifting procedures are performed
routinely to provide the required height
of proper and stable bone tissue around
inserted dental implants.1,2 The surgicaltechnique of maxillary sinus Schneiderian
membrane (MSSM) lifting with immedi-
ate/simultaneous installation of dental
implants, generally results in significantbone formation.1,3–8 The recently reported
graftless MSSM elevation procedure and
the subsequent augmentation of bone have
greatly changed our perspective of boneociation of Oral and Maxillofacial Surgeons. This is
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1148 Falah et al.
Fig. 1. Sinus lifting procedure. (A) The maxillary sinus lateral wall is exposed and a bone window
is cut out. (B) Sinus elevation. (C) and (D) ‘Tenting’ of the sinus mucosal lining membrane by
simultaneous installation of implants in the residual sub-antral bone. (E) and (F) The dental
membrane is placed over the lateral window and the incision is then closed with resorbable sutures.neoformation potential.8–10 The blood clot
formed under the lifted MSSM appears to
be of critical importance in bone neoforma-
tion potential, precluding the need for ex-
ogenous graft materials.11–13 Computed
tomography (CT) data have demonstrated
no difference in bone density following the
use of allogeneic filling materials versus
following a graftless sinus procedure.12The
compartment made in-between the MSSM
and the maxillary bone floor, including the
blood clot formed, bears very high osteo-
genic potential, and as such, is assumed to
be one of the most important factors dictat-
ing the success of graftless sinus proce-
dures.11–13 Review papers have recently
concluded that ungrafted sinus lifting is a
reliable and established technique; howev-
er, the exact mechanism of bone augmen-
tation is still not well understood.8,9
Recent studies have provided some in-
sight into the mechanism and source of
osteoprogenitor cells leading to bone for-
mation following graftless sinus lifting.14,15
The osteogenic potential of the MSSM and
the bone-forming cells beneath the mem-
brane has been demonstrated in both in
vitro and in vivo assays, and osteoprogeni-
tor cells originating from the sinus mem-
brane have been shown to drive bone
formation.14,15 Subcutaneous bone forma-
tion after transplantation of a MSSM folded
around a fibrin clot has also been demon-
strated.14 These studies strongly indicate
the importance of the MSSM and its com-
ponent cells, as well as the fibrin clot, to a
certain extent, in the bone formation pro-
cesses.
On the other hand, Cicconetti et al.16
and Bianco and Robey17 have proposed
that the osteogenic potential is inherent to
the sinus maxillary bone floor or, more
accurately, to the maxillary tuberosity and
the maxillary/mandibular periosteum.
These bone sites have been shown to be
the sources of osteoprogenitor cells, as
sample explants of the maxillary tuberos-
ity and mandibular periosteum have been
found to contain cells with early expressed
osteogenic markers that could form bone
structures upon ectopic transplantation.16
In the present clinical study, 18 patients
underwent 30 graftless maxillary sinus lift-
ing procedures followed by the immediate
insertion of 72 dental implants without
exogenous graft material filler. Only blood
clots occurring from bleeding due to the
surgical procedure filled the compartment
beneath the tented MSSM. The aim of this
study was to assess new bone formation
within and over the compartment created
and around implants under the sinus muco-
sal lining in the sinus floor. Moreover, it
was aimed to assess the biological contri-bution of either or both the MSSM and the
maxillary floor to the new bone formation,
as well as to analyze the new bone tissue
formed near the basal floor and the elevated
membrane at 6 months after the procedure.
Materials and methods
Patient selection
The study patients (n = 18) were partially
or completely edentulous in the posterior
maxilla and required unilateral or bilateral
maxillary sinus augmentation.
Study design
All participants were informed about the
surgical treatment procedure and provided
their written consent to participate in the
study. The study was approved by the
necessary ethics committee and was con-
ducted between 2011 and 2013. Patients
were only eligible if they were physically
healthy, with no medical history of sys-
temic or local diseases, such as certain
bone metabolism disorders that could con-
traindicate sinus or implant surgery. A
ridge bone height of at least 4 mm, re-
quired for primary stabilization of the
implants, was a key inclusion criterion.
The complexities of implant rehabilitation
were described and the patients were pro-
vided with necessary information about
the procedure, including the prognosis,
complications, and any potential hazard.
Smoking was not considered a contraindi-
cation, but patients were informed that it
can reduce success rates of the procedure
and compromise the sinus lift.
The surgical protocol and the criteria
described by Buser et al.18 were used to
evaluate the osseointegration of implants.
In accordance with the criteria, implant
mobility was considered a failure and
required implant removal. The implantsurvival rate was calculated by measuring
the time elapsed from implant placement
to the last follow-up visit or implant re-
moval. For radiographic analysis, preop-
erative panoramic view examinations
(OC200D; Instrumentarium Dental, Tuu-
sula, Finland) and dental cone beam com-
puted tomography (CBCT) scans (i-CAT;
Imaging Sciences, Hatfield, PA, USA)
were performed to evaluate the available
maxillary alveolar bone height, as well as
any possible existing sinus pathology.
Software programs were used to calculate
the existing preoperative residual bone
height in millimetres. The measurement
of the elevated membrane was performed
using the apical point of the implant as a
standard reference point after the surgery.
Surgery
All participants received dexamethasone
(6 mg) 1 h before surgery and oral pro-
phylactic antibiotics 45 min before sur-
gery. Patients routinely received 2 g
amoxicillin–clavulanate before surgery.
In the case of a penicillin allergy,
600 mg clindamycin was administered.
Antibiotics were administered postopera-
tively for 10 days: 875 mg amoxicillin–
clavulanate twice a day, or 300 mg clin-
damycin three times daily for those with a
penicillin allergy. The surgery was per-
formed under local anaesthesia (2% lido-
caine and 1:100,000 epinephrine).
After exposing the posterior maxillary
edentulous area and the lateral maxillary
sinus wall using a crestal incision, a buccal
mucoperiosteal flap was raised and an
osteotomy made in the anterior wall of
the sinus using a 5-mm-radius round drill
in an oval or rectangular fashion, 5–6 mm
cranial to the intended implant site
(Fig. 1). After exposing the sinus mem-
brane, it was dissected carefully from the
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Fig. 3. Locations of the installed implants and
‘tenting’ of the sinus mucosal lining mem-
brane. Points 1 and 2 indicate the biopsy sites
in the newly formed bone; biopsies were taken
6 months after surgery.sinus floor walls with a flat, blunt-edged
instrument. In the case of small perfora-
tions of the sinus membrane, the mucosal
lining was treated by further dissection of
the mucosal lining and folding of the
perforated site.
After sinus membrane elevation, all
implants (MIS Implants Technologies
Ltd, Carmel, Israel) were inserted simulta-
neously in the residual sub-antral bone. The
remaining bone height was measured with a
depth gauge probe during surgery, and
recorded.
In the case of minimal residual alveolar
bone height (4 mm), primary implant sta-
bility was secured by preparing a hole
smaller than that described in the original
dental implant installation protocol.1 The
compartment around the implants under
the sinus mucosal lining in the sinus floor
was allowed to fill with blood from sur-
rounding bleeding, and a dental mem-
brane (MIS Implants Technologies Ltd)
was placed over the open window before
the incision was closed with resorbable
sutures (Vicryl 3-0; Ethicon Inc. Somer-
ville, NJ, USA) (Fig. 1).
Postoperative instructions
Patients were instructed not to blow their
nose for 2 weeks after the surgery. Post-
operative panoramic radiographs and CT
scans were performed during and after
the 6-month healing period, after which
the implant was assumed to have inte-
grated. Dental CBCT scans were taken
before the second-stage procedure. Dur-
ing the uncovering procedure (Fig. 2), 30
cylindrical bone biopsies were taken
from two levels with a 3-mm-wide tre-
phine bur: 15 biopsies were taken from
the newly formed bone near the basal
bone and 15 biopsies were taken from
the newly formed bone near the elevated
membrane (points 1 and 2, illustrated in
Fig. 3). The site of each biopsy was
determined after measurements were
obtained from the 6-month postoperative
CT scan.Fig. 2. Exposure of the implants at 6 months p
specimens. (A) Exposure of the healed window
collection from the lateral wall, as indicated in Fig
of the incision with resorbable sutures.Bone gain height evaluation
For the radiographic analysis, panoramic
view (OC200D; Instrumentarium Dental)
and dental CBCT scan (i-CAT; Imaging
Sciences) examinations were performed to
measure and evaluate the existing maxil-
lary alveolar bone height before and at 6
months after surgery. The gain in bone
height was measured by comparing the
preoperative and final dental CT scans
using special software programs. Bone
height is presented in millimetres.
Histomorphometric evaluation
The histomorphometric evaluation was
conducted according to the protocol of
Moon et al.19Histomorphometric data were
obtained from the bone biopsies retrieved
from both sites in the lateral window (i.e.,
points 1 and 2 in Fig. 3). Biopsy specimens
were immediately fixed in 4% formalde-
hyde (24 h, 4 8C) and decalcified in 10%
ethylenediaminetetraacetic acid solution
for 10 days. Thereafter, specimens were
dehydrated in an ascending alcohol series,
then embedded in paraffin, and sliced into
5-mm-thick sections parallel to the longi-
tudinal axis. Sections were stained with
Mayer’s haematoxylin and eosin as well
as trichrome stain, and visualized by light
microscopy. Using a computerized tech-
nique, the sections were evaluated histo-
morphometrically and photomicrographs
were taken using an Olympus BH2 micro-
scope equipped with an Olympus DP50
digital camera (Olympus Optical Compa-
ny, Tokyo, Japan). After digitization of theost-surgery and the collection of bone biopsy
 and successful dental implant. (B) Biopsy
. 3. (C) Installation of healing cups and closurepicture, histomorphometric data were col-
lected by a picture analysis program (iMT
Image Analysis Software; iMTechnology,
Daejeon, Korea).19The ratio of mineralized
bone tissue to the total tissue volume was
used to calculate the total bone volume.20
Statistical analysis
Comparison of the mineralized bone vol-
ume pre- and post-surgery was performed
using the paired Student t-test. Two-tailed
P-values of 0.05 were considered sta-
tistically significant. Data are expressed as
mean values of bone height (mm) or per-
centage (%)  standard deviation (SD).
Results
The study population comprised eight men
and 10 women, of ages ranging from 38 to
60 years (mean 52 years). Thirty sinus lift
procedures (12 bilateral and six unilateral)
were performed, followed by the place-
ment of 72 implants. During the healing
period, the patients had no significant
complications or any other signs or symp-
toms of infection or diseases in the maxil-
lary sinus, except for minor postoperative
physiological swelling. Three small sinus
membrane perforations (2 mm) occurred
during membrane elevation and these
were managed with further dissection of
the mucosal lining and folding of the
perforation site, which enabled formation
of a blood clot around the implants. Out of
the 72 implants placed, only four failed,
indicating a 94% overall implant survival
rate. Of the failed implants, only one
fixture was clinically mobile at the time
of second-stage surgery at 6 months, and
this implant was removed; the other im-
plant failures arose due to insufficient
primary stability in the residual bone
height. All other implants were stable.
Patients were followed for 1 year after
prosthesis placement; no complications
were observed.
In all cases, the new bone formation was
notable, with good continuity with the
native sinus floor (Fig. 4). The newly
formed bone on the maxillary sinus floor
was clearly discernible around and on the
apical side of the dental implants (Fig. 4). In
parallel, apparent radiographic differences
between non-perforated and perforated
sites, as well as cases of ongoing marginal
bone loss around the implants, were not
noted. The preoperative residual bone
height varied from 4 mm to 7 mm and
the average bone thickness of the sub-antral
bone was 5.61  1.2 mm (Fig. 5). At 6
months after surgery, no signs of infection
in the maxillary sinus were observed. An
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Fig. 4. Radiographic evaluation of new bone consolidation on the maxillary sinus floor.
Preoperative and postoperative panoramic CT scan views of two cases are presented. (A)
Preoperative bilateral partially edentulous maxillary posterior sites. (B) Postoperative CT scan
panoramic view at 6 months after maxillary sinus lifting and implant insertion. (C, C0)
Preoperative coronal or sagittal sections of the respective CT scan of the right and left maxillary
sinus. (D, D0) Postoperative coronal or sagittal sections of the respective CT scan of the right and
left maxillary sinus after 6 months.apparent increase in alveolar bone height
was observed radiographically (Fig. 4), and
was shown quantitatively, with an average
bone height of 11.76  1.2 mm at 6 monthsFig. 5. Preoperative and postoperative alveola
insertion, as determined from radiographic im
maxillary floor (P < 0.0001), as well as bone gpost-surgery, a net bone gain of
6.14  1.34 mm (Fig. 5).
Bone biopsies were collected from two
different sites in the newly formed bone:r bone height on the side of dental implant
ages. The graph presents bone height at the
ain.15 biopsies were taken from point 1 (near
the apical side of the dental implant) and
15 from point 2 (near the baseline alveolar
bone) (Fig. 3). Relatively well-arranged
trabeculae were observed, without evi-
dence of inflammation or foreign body
reaction. The blood-filled area contained
arranged woven bone tissue. The deposi-
tion of new bone was apparent from the
proximity of the repositioned bony win-
dow (Fig. 2). The percentage of vital bone
volume in the blood clot-filled area ranged




Bone graft material is considered a pre-
requisite for the clinical success of dental
implants inserted into the augmented max-
illary sinus. In the current clinical study, it
was found that new bone can form directly
on and around inserted dental implants
without the use of bony substitutes. Thus,
the cost-effectiveness and time-saving
benefits are obvious, as instead of using
autogenous bone or allografts, which in-
volve a remodelling period of 6 months or
9–12 months, respectively, implants can
be placed at the time of sinus lifting and
left to osseointegrate without bone substi-
tutes.1,21 While the rate of failure with this
technique is similar to those of conven-
tional procedures, there is less contamina-
tion associated with this procedure, as no
external grafts and/or additional surgeries
are involved.
With this line of reasoning, a broad and
firm consensus has been established re-
garding the importance of blood clot for-
mation, which serves as autogenous graft
filler material for bone regeneration during
graftless maxillary sinus lifting.8–10 Nu-
merous materials, including the blood clot,
have been tested and compared as graft
fillers. The blood clot bears excellent
growth factor activity, which initiates
and promotes bone formation.22 The
osteoinductive properties of the blood clot
alone have also been stressed in various
studies.10,23 The authors of the present
study believe that because implant place-
ment was immediate with this surgical
technique and sinus membrane tenting
was maintained by the implants, clot for-
mation throughout the entire sinus com-
partment was feasible.
The current study demonstrated graft-
less bone neoformation beneath the
MSSM, which was tented by direct place-
ment of implants, maintaining a cavity for
blood clot formation. As the only graft
filler of this space between the sinus
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Fig. 6. Evaluation of newly formed bone in the maxillary floor via biopsies retrieved from two
sites in the lateral wall (n = 15 per site). (A) Histomorphometric data obtained from the newly
formed bone (% of bone volume  SD). (B) and (C) Representative histological haematoxylin
and eosin-stained biopsy sections. (D) and (E) Representative histological trichrome-stained
biopsy sections. For all histology sections: magnification 4 for the left panel and magnification
10 for the right panel.membrane and basal bone, the blood clot
was later entirely replaced by newly
formed bone (Fig. 4). The mean bone
height gain of the newly formed bone
within the first 6 months of surgery was
6.14  1.34 mm (Fig. 5). The percentage
of newly formed bone determined near the
basal floor and near the elevated mem-
brane was fairly similar, and the histolog-
ical analysis confirmed perfect vital bone
formation (Fig. 6). Based on these results,
it is postulated that the bone formation was
initiated from within the fibrin scaffold or
clot, giving rise to arranged woven bone
tissue, as seen in the histological sections
(Fig. 6). These results strongly suggest
that the MSSM and maxillary bone floor
are most likely the source and origin of
osteoprogenitor cells. A recent study in the
canine model indicated that the surround-
ing bony walls and the MSSM of the
maxillary sinus bear the osteogenic capa-
bility, with the MSSM appearing to dem-
onstrate lesser osteogenic potential.24
Since the graftless procedure approach
is well documented in the literature, the
present study was directed towards the
important investigation of the mechanism
and elements responsible for graftless si-
nus augmentation. Although the number
of patients and biopsies on which the study
relied was restricted to a certain extent, the
experimental design and the results have
provided a significant indication that the
MSSM and the maxillary sinus floor con-
tribute to bone formation within the sinus.
According to previous studies by this
study group, the inherent osteogenic po-
tential of the MSSM arises from its resi-
dent osteoprogenitor cells, which migrate
to the fibrin clot and differentiate, leading
to bone formation on and around the
inserted implants.14,15 The fibrin clot,
which acts as a space retainer and provides
an advantageous microenvironment or
natural scaffold, also has a potentially
beneficial effect on triggering the osteo-
genic potential of the cells residing within
the MSSM.25 These results are in agree-
ment with those of another study, which
showed that the injection of peripheral
venous blood appeared to be beneficial
for new bone formation in a graft-free
maxillary sinus augmentation procedure.4
The traumatic sinus lifting procedure
and subsequent bleeding, ending with
the formation of fibrin or a blood clot,
may stimulate cells with osteogenic and
probably angiogenic potential to migrate
to the surgical site. Through the healing
process, these cells can differentiate to
osteoblasts and vascular cells and the clot
can serve as a scaffold, creating a natural
construct or a centre for the initiation of
1152 Falah et al.new bone formation. As indicated, mes-
enchymal stem cells (MSCs) derived from
peripheral blood may contribute to the
bone formation in the sinus compart-
ment.26 These cells, although present in
the peripheral circulating blood in low
numbers, can be mobilized in large num-
bers from bone marrow to tissues under-
going traumatic or damaging events.26
MSCs have been found in the blood of
trauma patients with multiple bone frac-
tures,27 suggesting that the disruption of
bone marrow leads to the release of MSCs
into the bloodstream. The cells then mi-
grate or are recruited to the injury site to
aid in tissue repair.28,29 A similar mecha-
nism may underlie the graftless sinus lift-
ing procedure, which involves controlled
trauma to the bone tissue and to the sinus
membrane.14 In sinus lifting procedures,
where tissue damage occurs, the periph-
eral blood haemorrhage fills the compart-
ment between the MSSM and the
maxillary sinus floor. This blood is most
likely very rich in MSCs and endothelial
progenitor cells (EPCs), which are
attracted by the stimulating factors of
the traumatic event of the procedure.
When this blood coagulates and forms a
fibrin clot, it locks or forms an anchorage
mesh for MSCs and EPCs. Cells can
thereafter differentiate to osteoprogenitors
and endothelial cells within the fibrin.
These cells, which are evenly distributed
throughout the fibrin scaffold or clot, may
simultaneously initiate the formation of
new bone tissue within the sinus compart-
ment created.
To this effect, it is hypothesized that
these osteoprogenitor cells migrate from
outside and from within the fibrin clot, and
serve as the main players in bone forma-
tion. The current clinical study confirms
and further proves the authors’ own
assumptions and those of other authors
that new bone formation arises from the
MSSM and floor upon graftless sinus lift-
ing immediately followed by dental im-
plant insertion. Based on the size of the
present case series, blood clots beneath the
MSSM tented by direct placement of
implants can be considered an autologous
osteogenic graft material filler onto which
osteoprogenitors can migrate, proliferate,
differentiate to osteoblasts, and regenerate
new bone through the healing process. The
similarities observed between bone biop-
sies taken from sites near the basal bone
and those from the elevated membrane
have only hinted to the possible role of
such cells.
In conclusion, this study described a
maxillary sinus lift technique followed
by immediate implant placement withoutthe use of graft materials. The procedure
was associated with a high success rate
and reduced the surgical morbidity asso-
ciated with autogenous grafts, as well as
some of the limitations of other osteocon-
ductive grafting materials. To further di-
rectly and effectively distinguish between
the roles of the MSSM and bony walls in
bone formation, we may suggest graftless
procedure similar to the study conducted
previously in canine model.24 Further
studies must also be conducted to explore
the possibility that cells are recruited from
the circulation to the formed clot and to
assess their role in bone formation.
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